The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADVANCED MICRO DEVICES INC COM 007903107   2,087,246 20,300 SH   SOLE   20,300 0 0
AMAZON COM INC COM 023135106   953,400 7,500 SH   SOLE   7,500 0 0
BROADCOM INC COM 11135F101   1,881,264 2,265 SH   SOLE   2,265 0 0
CADENCE DESIGN SYSTEM INC COM 127387108   1,054,350 4,500 SH   SOLE   4,500 0 0
HH&L ACQUISITION CO *W EXP 02/04/202 G39714129   11,320 400,000 SH   SOLE   400,000 0 0
KLA CORP COM NEW 482480100   2,063,970 4,500 SH   SOLE   4,500 0 0
MARVELL TECHNOLOGY INC COM 573874104   3,085,410 57,000 SH   SOLE   57,000 0 0
MICROSOFT CORP COM 594918104   1,010,400 3,200 SH   SOLE   3,200 0 0
NVIDIA CORPORATION COM 67066G104   3,131,928 7,200 SH   SOLE   7,200 0 0
ORACLE CORP COM 68389X105   423,680 4,000 SH   SOLE   4,000 0 0
TERADYNE INC COM 880770102   1,044,784 10,400 SH   SOLE   10,400 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117   30,900 750,000 SH   SOLE   750,000 0 0
YS BIOPHARMA CO LTD ORDINARY SHARES G9845F109   1,285,740 1,607,175 SH   SOLE   1,607,175 0 0
ZTO EXPRESS CAYMAN INC NOTE 1.500% 9/0 98980AAB1   9,425,975 9,700,000 PRN   SOLE   9,700,000 0 0